Companies: 49,247 Total Market Cap: 132727611808329.11

Bonraybio

TPE-6955

Electromedical and Electrotherapeutic Apparatus

Rank #23878

Market Cap 104.15 M

Volume 3,080

Price 5.30

Change (%) 2.44%

Country or region

Taiwan

Bonraybio's latest marketcap:

104.15 M

As of 05/21/2025, Bonraybio's market capitalization has reached $104.15 M. According to our data, Bonraybio is the 23878th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	104.15 M
Revenue (ttm)	0
Net Income (ttm)	0
Shares Out	19.65 M
EPS (ttm)	0
Forward PE	0.00
Ex-Dividend Date	03/27/2025
Earnings Date	05/12/2025

Market Cap Chart

Data Updated: 05/21/2025

Bonraybio's yearly market capitalization.

Bonraybio has seen its market value grow from NT$1.47 B to NT$3.14 B since 2023, representing a total increase of 113.95% and an annual compound growth rate (CAGR) of 72.56%.

Date	Market Cap	Change (%)
05/21/2025	NT$3.14 B	-0.33%
12/31/2024	NT$2.96 B	101.25%
12/29/2023	NT$1.47 B

Company Profile

About Bonraybio Co., Ltd.

Bonraybio Co., Ltd. is a development-stage company specializing in medical instruments and solutions for the male infertility market. Founded in 2015 and headquartered in Taichung, Taiwan, the company focuses on innovative diagnostic tools and consumables.

Key Products and Solutions

LensHooke X12 PRO – Semen analysis systems
LensHooke X1 PRO – Semen quality analyzers

Consumables

CS3 – Semen test slides
CA0/CA1 – Sperm separation solutions
CS1 – Semen test cassettes

Additional Offerings

X QC Reticles, X QC Video Tools, and X QC Beads – Quality control solutions
Sperm DNA Fragmentation Test Kits – Advanced diagnostic tools
S10 Data Consolidation Software – Streamlined data management

Frequently Asked Questions

As of 05/21/2025, Bonraybio (including the parent company, if applicable) has an estimated market capitalization of $104.15 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Bonraybio global market capitalization ranking is approximately 23878 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Taiwan
Founded	2015
IPO Date	n/a
Employees	n/a
CEO	Zhenteng Xu
Sector
Industry	Electromedical and Electrotherapeutic Apparatus
Address	No. 118, Gongye 9th Road Taichung, 41280 Taiwan
Website	https://bonraybio.com